Biomarin Pharmaceutical Inc (BMRN)

Payables turnover

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cost of revenue (ttm) US$ in thousands 577,872 626,244 606,613 580,235 579,574 519,158 519,318 529,610 521,422 509,669 502,176 483,669 476,129 463,378 467,314 470,515 476,903 562,159 533,064 524,272
Payables US$ in thousands 389,670 310,797 293,751 235,403 312,321 257,412 292,238 315,509 301,369 277,944 264,778 231,238 207,165 199,251 187,810 193,003 203,321 411,132 399,225 191,429
Payables turnover 1.48 2.01 2.07 2.46 1.86 2.02 1.78 1.68 1.73 1.83 1.90 2.09 2.30 2.33 2.49 2.44 2.35 1.37 1.34 2.74

September 30, 2025 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $577,872K ÷ $389,670K
= 1.48


Peer comparison

Sep 30, 2025

Company name
Symbol
Payables turnover
Biomarin Pharmaceutical Inc
BMRN
1.48
Arrowhead Pharmaceuticals Inc
ARWR
0.99
Regeneron Pharmaceuticals Inc
REGN
2.30